Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MabCure, Inc.
No Price
Closing Price OTC 28.04.2026:
0,0004 USD
28.04.2026 20:00
Current Prices from MabCure, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
MBCI
USD
28.04.2026 20:00
0,0004 USD
-0,0001 USD
-20,00 %
Company Profile for MabCure, Inc. Share
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
